Lanoxin tablet/adult indications and dosage: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lanoxin tablet}} | |||
{{ | {{CMG}}; {{AE}} {{AK}} | ||
{{CMG}} | |||
===FDA-Labeled Indications and Dosage (Adult)=== | ===FDA-Labeled Indications and Dosage (Adult)=== | ||
Line 22: | Line 20: | ||
==References== | |||
{{DrugReflist}} | {{DrugReflist}} |
Revision as of 16:40, 20 March 2014
Lanoxin tablet® |
---|
Black Box Warning |
Adult Indications and Dosage
|
Pediatric Indications and Dosage
|
Contraindications |
Warnings |
Adverse Reactions
|
Drug Interactions |
Use in Specific Populations
|
Routes and Preparations
|
IV Compatibility |
Overdosage |
Pharmacology
|
Clinical Studies |
How Supplied |
Images
|
Patient Information
|
Combined Alcohol Use |
Look-Alike Drug Names |
Drug Shortage Status |
Price |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
FDA-Labeled Indications and Dosage (Adult)
Heart failure
Loading dose"': 10-15 mcg/kg half of dose administered initially, and the other two quarters are given every 6-8 hours twice.
Maintenance dose: 3.4-5.1 mcg/kg/day once daily.
Atrial fibrillation
Loading dose"': 10-15 mcg/kg half of dose administered initially, and the other two quarters are given every 6-8 hours twice.
Maintenance dose: 3.4-5.1 mcg/kg/day once daily.